TH, S., & P, S. (2016). Matriptase, Protease-activated Receptor 2, and Idiopathic Pulmonary Fibrosis. Further Evidence for Signaling Pathway Redundancy in this Difficult-to-Treat Disease? American journal of respiratory and critical care medicine, 193(8), 816. https://doi.org/10.1164/rccm.201512-2319ED
Chicago Style (17th ed.) CitationTH, Sisson, and Spagnolo P. "Matriptase, Protease-activated Receptor 2, and Idiopathic Pulmonary Fibrosis. Further Evidence for Signaling Pathway Redundancy in This Difficult-to-Treat Disease?" American Journal of Respiratory and Critical Care Medicine 193, no. 8 (2016): 816. https://doi.org/10.1164/rccm.201512-2319ED.
MLA (9th ed.) CitationTH, Sisson, and Spagnolo P. "Matriptase, Protease-activated Receptor 2, and Idiopathic Pulmonary Fibrosis. Further Evidence for Signaling Pathway Redundancy in This Difficult-to-Treat Disease?" American Journal of Respiratory and Critical Care Medicine, vol. 193, no. 8, 2016, p. 816, https://doi.org/10.1164/rccm.201512-2319ED.